mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 3 Business Days
mRNA Synthesis Raw Materials Market Growth & Trends
The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.1% from 2023 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.
The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.
Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.
Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.
Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.
However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.
mRNA Synthesis Raw Materials Market Report Highlights
mRNA Synthesis Raw Materials Market Growth & Trends
The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.1% from 2023 to 2030. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.
The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.
Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.
Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.
Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.
However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.
mRNA Synthesis Raw Materials Market Report Highlights
- The capping agents segment held the largest share of 40.6% in 2022 owing to the advancements in the capping technology and their applications in the biopharma industry and research
- By application, the vaccine production segment captured the highest share of 85.30% in 2022. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that use cell-culture-based production routes, which are often prone to failure
- North America held the highest revenue share of 35.5% in 2022, due to the presence of key players, the availability of an established commercial infrastructure for biotechnology and pharmaceutical companies, and high research and development investments in the region
- By end-user, the biopharmaceutical and pharmaceutical companies segment dominated the market in 2022 due to the increasing investments in the biopharmaceutical sector and the rising pipeline, which has boosted the need for mRNA synthesis raw materials
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS, & SCOPE
3.1 Parent Market Analysis
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing Academic And Industrial Interest In mRNA Technology
3.2.1.2 Advantages Of mRNA Vaccines
3.2.1.3 Increasing Funding For mRNA Research
3.2.2 Market Restraint Analysis
3.2.2.1 Nonexistence Of Effective Government Regulations For mRNA - Based Product Approvals
3.2.2.2 High Cost Of mRNA Synthesis Raw Materials
3.2.3 Market Challange Analysis
3.2.3.1 Lack Of Long - Lasting And Affordable Manufacturing Processes
3.3 Penetration &Growth Prospect Mapping
3.4 mRNA Synthesis Raw Materials Market - Porter’s Analysis
3.5 mRNA Synthesis Raw Materials Market - Swot Analysis
3.6 Covid - 19 Impact Analysis
CHAPTER 4 TYPE BUSINESS ANALYSIS
4.1 mRNA Synthesis Raw Materials Market - Type Movement Analysis
4.2 Capping Agents
4.2.1 Global Capping Agents Market, 2018 - 2030 (USD Million)
4.3 Nucleotides
4.3.1 Global Nucleotides Market, 2018 - 2030 (USD Million)
4.4 Plasmid Dna
4.4.1 Global Plasmid Dna Market, 2018 - 2030 (USD Million)
4.5 Others
4.5.1 Global Other Types Market, 2018 - 2030 (USD Million)
CHAPTER 5 APPLICATION BUSINESS ANALYSIS
5.1 mRNA Synthesis Raw Materials Market - Application Movement Analysis
5.2 Therapeutics Production
5.2.1 Global Therapeutics Production Market, 2018 - 2030 (USD Million)
5.3 Vaccine Production
5.3.1 Global Vaccine Production Market, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Global Other Applications Market, 2018 - 2030 (USD Million)
CHAPTER 6 END - USER BUSINESS ANALYSIS
6.1 mRNA Synthesis Raw Materials Market - End User Movement Analysis
6.2 Biopharmaceutical & Pharmaceutical Companies
6.2.1 Global Biopharmaceutical & Pharmaceutical Companies, 2018 - 2030 (USD Million)
6.3 Cros & Cmos
6.3.1 Global Cros & Cmos, 2018 - 2030 (USD Million)
6.4 Academic And Research Institutions
6.4.1 Global Academic And Research Institutions, 2018 - 2030 (USD Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 mRNA Synthesis Raw Materials Market: Regional Movement Analysis
7.2 North America
7.2.1 Swot Analysis
7.2.1.1 North America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 Competitive Scenario
7.2.2.3 Regulatory Framework
7.2.2.4 U.S. mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Key country dynamics
7.2.3.2 Competitive scenario
7.2.3.3 Regulatory framework
7.2.3.4 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Swot Analysis
7.3.1.1 Europe mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Key Country Dynamics
7.3.2.2 Competitive Scenario
7.3.2.3 Regulatory Framework
7.3.2.4 Germany mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.3 U.K.
7.3.3.1 Key Country Dynamics
7.3.3.2 Competitive Scenario
7.3.3.3 Regulatory Framework
7.3.3.4 Uk mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 Competitive Scenario
7.3.4.3 Regulatory Framework
7.3.4.4 France mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Competitive Scenario
7.3.5.3 Regulatory Framework
7.3.5.5 Italy mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Competitive Scenario
7.3.6.3 Regulatory Framework
7.3.6.4 Spain mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.7 Denmark
7.3.7.1 Key Country Dynamics
7.3.7.2 Competitive Scenario
7.3.7.3 Regulatory Framework
7.3.7.4 Denmark mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.8 Sweden
7.3.8.1 Key Country Dynamics
7.3.8.2 Competitive Scenario
7.3.8.3 Regulatory Framework
7.3.8.4 Sweden mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Key country dynamics
7.3.9.2 Competitive scenario
7.3.9.3 Regulatory framework
7.3.9.4 Norway mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Swot Analysis
7.4.1.1 Asia Pacific mRNA Synthesis Raw Materials, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Regulatory Framework
7.4.2.4 Japan mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 Regulatory Framework
7.4.3.4 China mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 Competitive Scenario
7.4.4.3 Regulatory Framework
7.4.4.4 India mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Competitive Scenario
7.4.5.3 Regulatory Framework
7.4.5.4 Australia mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 Key Country Dynamics
7.4.6.2 Competitive Scenario
7.4.6.3 Regulatory Framework
7.4.6.4 South Korea mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.7 Thailand
7.4.7.1 Key country dynamics
7.4.7.2 Competitive scenario
7.4.7.3 Regulatory framework
7.4.7.4 Thailand mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Swot Analysis
7.5.1.1 Latin America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Regulatory Framework
7.5.2.4 Brazil mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Regulatory Framework
7.5.3.4 Mexico mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Key country dynamics
7.5.4.2 Competitive scenario
7.5.4.3 Regulatory framework
7.5.4.4 Argentina mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.6 Middle East & Africa
7.6.1 Swot Analysis
7.6.1.1 Mea mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 Key country dynamics
7.6.2.2 Competitive scenario
7.6.2.3 Regulatory framework
7.6.2.4 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Key country dynamics
7.6.3.2 Competitive scenario
7.6.3.3 Regulatory framework
7.6.3.4 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 Key country dynamics
7.6.4.2 Competitive scenario
7.6.4.3 Regulatory framework
7.6.4.4 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5 KUWAIT
7.6.5.1 Key country dynamics
7.6.5.2 Competitive scenario
7.6.5.3 Regulatory framework
7.6.5.4 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Participant’s Overview
8.1.1 F. Hoffmann - La Roche Ltd.
8.1.2 Jena Bioscience Gmbh
8.1.3 Merck KGaA
8.1.4 Yeasen Biotechnology (Shanghai) Co.,Ltd.
8.1.5 BOC Sciences
8.1.6 Thermo Fisher Scientific, Inc.
8.1.7 Maravai Lifesciences
8.1.8 New England Biolabs
8.1.9 Creative Biogene
8.1.10 Hongene
8.2 Financial Performance
8.3 Participant Categorization
8.3.1 Market Leaders
8.3.1.1 mRNA Synthesis Raw Materials Market Share Analysis, 2022
8.3.2 Strategy Mapping
8.3.2.1 Expansion
8.3.2.2 Acquisition
8.3.2.3 Collaborations
8.3.2.4 Product/service launch
8.3.2.5 Partnerships
8.3.2.6 Others
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS, & SCOPE
3.1 Parent Market Analysis
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing Academic And Industrial Interest In mRNA Technology
3.2.1.2 Advantages Of mRNA Vaccines
3.2.1.3 Increasing Funding For mRNA Research
3.2.2 Market Restraint Analysis
3.2.2.1 Nonexistence Of Effective Government Regulations For mRNA - Based Product Approvals
3.2.2.2 High Cost Of mRNA Synthesis Raw Materials
3.2.3 Market Challange Analysis
3.2.3.1 Lack Of Long - Lasting And Affordable Manufacturing Processes
3.3 Penetration &Growth Prospect Mapping
3.4 mRNA Synthesis Raw Materials Market - Porter’s Analysis
3.5 mRNA Synthesis Raw Materials Market - Swot Analysis
3.6 Covid - 19 Impact Analysis
CHAPTER 4 TYPE BUSINESS ANALYSIS
4.1 mRNA Synthesis Raw Materials Market - Type Movement Analysis
4.2 Capping Agents
4.2.1 Global Capping Agents Market, 2018 - 2030 (USD Million)
4.3 Nucleotides
4.3.1 Global Nucleotides Market, 2018 - 2030 (USD Million)
4.4 Plasmid Dna
4.4.1 Global Plasmid Dna Market, 2018 - 2030 (USD Million)
4.5 Others
4.5.1 Global Other Types Market, 2018 - 2030 (USD Million)
CHAPTER 5 APPLICATION BUSINESS ANALYSIS
5.1 mRNA Synthesis Raw Materials Market - Application Movement Analysis
5.2 Therapeutics Production
5.2.1 Global Therapeutics Production Market, 2018 - 2030 (USD Million)
5.3 Vaccine Production
5.3.1 Global Vaccine Production Market, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Global Other Applications Market, 2018 - 2030 (USD Million)
CHAPTER 6 END - USER BUSINESS ANALYSIS
6.1 mRNA Synthesis Raw Materials Market - End User Movement Analysis
6.2 Biopharmaceutical & Pharmaceutical Companies
6.2.1 Global Biopharmaceutical & Pharmaceutical Companies, 2018 - 2030 (USD Million)
6.3 Cros & Cmos
6.3.1 Global Cros & Cmos, 2018 - 2030 (USD Million)
6.4 Academic And Research Institutions
6.4.1 Global Academic And Research Institutions, 2018 - 2030 (USD Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 mRNA Synthesis Raw Materials Market: Regional Movement Analysis
7.2 North America
7.2.1 Swot Analysis
7.2.1.1 North America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 Competitive Scenario
7.2.2.3 Regulatory Framework
7.2.2.4 U.S. mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Key country dynamics
7.2.3.2 Competitive scenario
7.2.3.3 Regulatory framework
7.2.3.4 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Swot Analysis
7.3.1.1 Europe mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Key Country Dynamics
7.3.2.2 Competitive Scenario
7.3.2.3 Regulatory Framework
7.3.2.4 Germany mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.3 U.K.
7.3.3.1 Key Country Dynamics
7.3.3.2 Competitive Scenario
7.3.3.3 Regulatory Framework
7.3.3.4 Uk mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 Competitive Scenario
7.3.4.3 Regulatory Framework
7.3.4.4 France mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Competitive Scenario
7.3.5.3 Regulatory Framework
7.3.5.5 Italy mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Competitive Scenario
7.3.6.3 Regulatory Framework
7.3.6.4 Spain mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.7 Denmark
7.3.7.1 Key Country Dynamics
7.3.7.2 Competitive Scenario
7.3.7.3 Regulatory Framework
7.3.7.4 Denmark mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.8 Sweden
7.3.8.1 Key Country Dynamics
7.3.8.2 Competitive Scenario
7.3.8.3 Regulatory Framework
7.3.8.4 Sweden mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Key country dynamics
7.3.9.2 Competitive scenario
7.3.9.3 Regulatory framework
7.3.9.4 Norway mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Swot Analysis
7.4.1.1 Asia Pacific mRNA Synthesis Raw Materials, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Regulatory Framework
7.4.2.4 Japan mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 Regulatory Framework
7.4.3.4 China mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 Competitive Scenario
7.4.4.3 Regulatory Framework
7.4.4.4 India mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Competitive Scenario
7.4.5.3 Regulatory Framework
7.4.5.4 Australia mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 Key Country Dynamics
7.4.6.2 Competitive Scenario
7.4.6.3 Regulatory Framework
7.4.6.4 South Korea mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.4.7 Thailand
7.4.7.1 Key country dynamics
7.4.7.2 Competitive scenario
7.4.7.3 Regulatory framework
7.4.7.4 Thailand mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Swot Analysis
7.5.1.1 Latin America mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Regulatory Framework
7.5.2.4 Brazil mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Regulatory Framework
7.5.3.4 Mexico mRNA Synthesis Raw Materials Market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Key country dynamics
7.5.4.2 Competitive scenario
7.5.4.3 Regulatory framework
7.5.4.4 Argentina mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
7.6 Middle East & Africa
7.6.1 Swot Analysis
7.6.1.1 Mea mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 Key country dynamics
7.6.2.2 Competitive scenario
7.6.2.3 Regulatory framework
7.6.2.4 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Key country dynamics
7.6.3.2 Competitive scenario
7.6.3.3 Regulatory framework
7.6.3.4 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 Key country dynamics
7.6.4.2 Competitive scenario
7.6.4.3 Regulatory framework
7.6.4.4 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
7.6.5 KUWAIT
7.6.5.1 Key country dynamics
7.6.5.2 Competitive scenario
7.6.5.3 Regulatory framework
7.6.5.4 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Participant’s Overview
8.1.1 F. Hoffmann - La Roche Ltd.
8.1.2 Jena Bioscience Gmbh
8.1.3 Merck KGaA
8.1.4 Yeasen Biotechnology (Shanghai) Co.,Ltd.
8.1.5 BOC Sciences
8.1.6 Thermo Fisher Scientific, Inc.
8.1.7 Maravai Lifesciences
8.1.8 New England Biolabs
8.1.9 Creative Biogene
8.1.10 Hongene
8.2 Financial Performance
8.3 Participant Categorization
8.3.1 Market Leaders
8.3.1.1 mRNA Synthesis Raw Materials Market Share Analysis, 2022
8.3.2 Strategy Mapping
8.3.2.1 Expansion
8.3.2.2 Acquisition
8.3.2.3 Collaborations
8.3.2.4 Product/service launch
8.3.2.5 Partnerships
8.3.2.6 Others
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 4 Global mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 5 Global mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 6 Global mRNA synthesis raw materials market, by region, 2018 - 2030 (USD Million)
Table 7 North America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 8 North America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 9 North America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 10 North America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 11 U.S. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 12 U.S. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 13 U.S. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 14 Canada mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 15 Canada mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 16 Canada mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 17 Europe mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 18 Europe mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 19 Europe mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 20 Europe mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 21 Germany mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 22 Germany mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 23 Germany mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 24 U.K. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 25 U.K. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 26 U.K. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 27 France mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 28 France mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 29 France mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 30 Italy mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 31 Italy mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 32 Italy mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 33 Spain mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 34 Spain mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 35 Spain mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 36 Denmark mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 37 Denmark mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 38 Denmark mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 39 Sweden mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 40 Sweden mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 41 Sweden mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 42 Norway mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 43 Norway mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 44 Norway mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 45 Asia Pacific mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 48 Asia Pacific mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 49 Japan mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 50 Japan mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 51 Japan mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 52 China mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 53 China mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 54 China mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 55 India mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 56 India mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 57 India mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 58 South Korea mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 59 South Korea mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 60 South Korea mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 61 Australia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 62 Australia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 63 Australia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 64 Thailand mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 65 Thailand mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 66 Thailand mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 67 Latin America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 69 Latin America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 70 Latin America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 71 Brazil mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 72 Brazil mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 73 Brazil mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 74 Mexico mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 75 Mexico mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 76 Mexico mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 77 Argentina mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 78 Argentina mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 79 Argentina mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 84 South Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 85 South Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 86 South Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 90 UAE mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 91 UAE mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 92 UAE mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 93 Kuwait mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 94 Kuwait mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 95 Kuwait mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 96 Participant’s overview
Table 97 Financial performance
Table 98 Key companies undergoing expansions
Table 99 Key companies undergoing acquisitions
Table 100 Key companies undergoing collaborations
Table 101 Key companies launching new products/services
Table 102 Key companies undergoing partnerships
Table 103 Key companies undertaking other strategies
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 4 Global mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 5 Global mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 6 Global mRNA synthesis raw materials market, by region, 2018 - 2030 (USD Million)
Table 7 North America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 8 North America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 9 North America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 10 North America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 11 U.S. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 12 U.S. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 13 U.S. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 14 Canada mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 15 Canada mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 16 Canada mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 17 Europe mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 18 Europe mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 19 Europe mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 20 Europe mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 21 Germany mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 22 Germany mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 23 Germany mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 24 U.K. mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 25 U.K. mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 26 U.K. mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 27 France mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 28 France mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 29 France mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 30 Italy mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 31 Italy mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 32 Italy mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 33 Spain mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 34 Spain mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 35 Spain mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 36 Denmark mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 37 Denmark mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 38 Denmark mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 39 Sweden mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 40 Sweden mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 41 Sweden mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 42 Norway mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 43 Norway mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 44 Norway mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 45 Asia Pacific mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 48 Asia Pacific mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 49 Japan mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 50 Japan mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 51 Japan mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 52 China mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 53 China mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 54 China mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 55 India mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 56 India mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 57 India mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 58 South Korea mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 59 South Korea mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 60 South Korea mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 61 Australia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 62 Australia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 63 Australia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 64 Thailand mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 65 Thailand mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 66 Thailand mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 67 Latin America mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 69 Latin America mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 70 Latin America mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 71 Brazil mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 72 Brazil mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 73 Brazil mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 74 Mexico mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 75 Mexico mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 76 Mexico mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 77 Argentina mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 78 Argentina mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 79 Argentina mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa mRNA synthesis raw materials market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 84 South Africa mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 85 South Africa mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 86 South Africa mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 90 UAE mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 91 UAE mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 92 UAE mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 93 Kuwait mRNA synthesis raw materials market, by type, 2018 - 2030 (USD Million)
Table 94 Kuwait mRNA synthesis raw materials market, by application, 2018 - 2030 (USD Million)
Table 95 Kuwait mRNA synthesis raw materials market, by end-user, 2018 - 2030 (USD Million)
Table 96 Participant’s overview
Table 97 Financial performance
Table 98 Key companies undergoing expansions
Table 99 Key companies undergoing acquisitions
Table 100 Key companies undergoing collaborations
Table 101 Key companies launching new products/services
Table 102 Key companies undergoing partnerships
Table 103 Key companies undertaking other strategies
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 mRNA synthesis raw materials market: Product outlook and key takeaways
Fig. 16 mRNA synthesis raw materials market: Product movement analysis
Fig. 17 Global capping agents market, 2018 - 2030 (USD Million)
Fig. 18 Global nucleotides market, 2018 - 2030 (USD Million)
Fig. 19 Global plasmid DNA market, 2018 - 2030 (USD Million)
Fig. 20 Global other mRNA synthesis raw materials, by type market, 2018 - 2030 (USD Million)
Fig. 21 mRNA synthesis raw materials market: Application outlook and key takeaways
Fig. 22 mRNA synthesis raw materials market: Application movement analysis
Fig. 23 Global therapeutics production market, 2018 - 2030 (USD Million)
Fig. 24 Global vaccine production market, 2018 - 2030 (USD Million)
Fig. 25 Global other applications market, 2018 - 2030 (USD Million)
Fig. 26 mRNA synthesis raw materials market: End-use outlook and key takeaways
Fig. 27 mRNA synthesis raw materials market: End-use movement analysis
Fig. 28 Global biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 29 Global CROs & CMOs market, 2018 - 2030 (USD Million)
Fig. 30 Global academic & research institutions market, 2018 - 2030 (USD Million)
Fig. 31 mRNA synthesis raw materials market: Regional outlook and key takeaways
Fig. 32 North America: SWOT Analysis
Fig. 33 North America mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 34 U.S. key country dynamics
Fig. 35 U.S. mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 36 Canada key country dynamics
Fig. 37 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 38 Europe: SWOT Analysis
Fig. 39 Europe mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Germany key country dynamics
Fig. 41 Germany mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 France key country dynamics
Fig. 43 France mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 U.K. key country dynamics
Fig. 45 U.K. mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Italy key country dynamics
Fig. 47 Italy mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Spain key country dynamics
Fig. 49 Spain mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Denmark key country dynamics
Fig. 51 Denmark mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Sweden key country dynamics
Fig. 53 Sweden mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Norway key country dynamics
Fig. 55 Norway mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific: SWOT Analysis
Fig. 57 Asia Pacific mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 China key country dynamics
Fig. 59 China mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 India key country dynamics
Fig. 61 India mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 South Korea key country dynamics
Fig. 63 South Korea mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Japan key country dynamics
Fig. 65 Japan mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Australia key country dynamics
Fig. 67 Australia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Thailand key country dynamics
Fig. 69 Thailand mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Latin America: SWOT Analysis
Fig. 71 Latin America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Brazil key country dynamics
Fig. 73 Brazil mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Mexico key country dynamics
Fig. 75 Mexico mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Argentina key country dynamics
Fig. 77 Argentina mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 MEA: SWOT Analysis
Fig. 79 MEA mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 South Africa key country dynamics
Fig. 81 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Saudi Arabia key country dynamics
Fig. 83 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 UAE key country dynamics
Fig. 85 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Kuwait key country dynamics
Fig. 87 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Market participant categorization
Fig. 89 mRNA synthesis raw materials market share analysis, 2022
Fig. 90 Strategy framework
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 mRNA synthesis raw materials market: Product outlook and key takeaways
Fig. 16 mRNA synthesis raw materials market: Product movement analysis
Fig. 17 Global capping agents market, 2018 - 2030 (USD Million)
Fig. 18 Global nucleotides market, 2018 - 2030 (USD Million)
Fig. 19 Global plasmid DNA market, 2018 - 2030 (USD Million)
Fig. 20 Global other mRNA synthesis raw materials, by type market, 2018 - 2030 (USD Million)
Fig. 21 mRNA synthesis raw materials market: Application outlook and key takeaways
Fig. 22 mRNA synthesis raw materials market: Application movement analysis
Fig. 23 Global therapeutics production market, 2018 - 2030 (USD Million)
Fig. 24 Global vaccine production market, 2018 - 2030 (USD Million)
Fig. 25 Global other applications market, 2018 - 2030 (USD Million)
Fig. 26 mRNA synthesis raw materials market: End-use outlook and key takeaways
Fig. 27 mRNA synthesis raw materials market: End-use movement analysis
Fig. 28 Global biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 29 Global CROs & CMOs market, 2018 - 2030 (USD Million)
Fig. 30 Global academic & research institutions market, 2018 - 2030 (USD Million)
Fig. 31 mRNA synthesis raw materials market: Regional outlook and key takeaways
Fig. 32 North America: SWOT Analysis
Fig. 33 North America mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 34 U.S. key country dynamics
Fig. 35 U.S. mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 36 Canada key country dynamics
Fig. 37 Canada mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
Fig. 38 Europe: SWOT Analysis
Fig. 39 Europe mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Germany key country dynamics
Fig. 41 Germany mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 France key country dynamics
Fig. 43 France mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 U.K. key country dynamics
Fig. 45 U.K. mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Italy key country dynamics
Fig. 47 Italy mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Spain key country dynamics
Fig. 49 Spain mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Denmark key country dynamics
Fig. 51 Denmark mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Sweden key country dynamics
Fig. 53 Sweden mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Norway key country dynamics
Fig. 55 Norway mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific: SWOT Analysis
Fig. 57 Asia Pacific mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 China key country dynamics
Fig. 59 China mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 India key country dynamics
Fig. 61 India mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 South Korea key country dynamics
Fig. 63 South Korea mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Japan key country dynamics
Fig. 65 Japan mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Australia key country dynamics
Fig. 67 Australia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Thailand key country dynamics
Fig. 69 Thailand mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Latin America: SWOT Analysis
Fig. 71 Latin America mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Brazil key country dynamics
Fig. 73 Brazil mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Mexico key country dynamics
Fig. 75 Mexico mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Argentina key country dynamics
Fig. 77 Argentina mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 MEA: SWOT Analysis
Fig. 79 MEA mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 South Africa key country dynamics
Fig. 81 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Saudi Arabia key country dynamics
Fig. 83 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 UAE key country dynamics
Fig. 85 UAE mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Kuwait key country dynamics
Fig. 87 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Market participant categorization
Fig. 89 mRNA synthesis raw materials market share analysis, 2022
Fig. 90 Strategy framework
